Teva Launches “Home Ground” Online Hub For Schizophrenia Support
New digital community from Teva
Teva Pharmaceuticals (NYSE: TEVA) has launched Home Ground Schizophrenia Community, an online hub designed to support people living with schizophrenia and their care partners with peer-driven information, tools and connection. The free platform is meant to address fragmented support by centralizing practical resources in one place and was built in collaboration with patients, care partners and mental health advocacy groups.
Focus on real-world daily challenges
Home Ground is structured around everyday needs rather than clinical jargon, aiming to help users manage symptoms, relationships and independence. Content emphasizes shared lived experience and emotional validation to reduce isolation, complementing—but not replacing—medical care.
Key features of Home Ground
- Symptom tracking and management tools: worksheets to track mood, sleep, stress and triggers to better inform provider visits.
- Emotional wellness resources: peer-informed videos and materials that normalize feelings for both individuals and care partners while providing coping strategies.
- Independent living guides: routines, reminders, goal-setting templates and community resource lists for housing and daily structure.
- Physical health prompts: checklists that reinforce sleep, activity and routine medical care alongside psychiatric treatment.
- In-person and virtual events: local and national gatherings designed to connect people living with schizophrenia and their care partners.
Investor perspective
For investors, Home Ground reinforces Teva’s positioning as a neuroscience-focused pharma company investing in wraparound support for complex mental health conditions, not just drug development. The initiative may help strengthen brand equity and patient loyalty across Teva’s CNS portfolio while aligning with broader trends toward holistic, community-based mental health care.
